Table 2

 Mortality (all-cause and cardiovascular disease) per 1000 person-years, by Health Assessment Questionnaire groups at baseline and year 1

Baseline HAQYear 1 HAQ
All (n = 1086)Followed-up to first year (n = 1010)All (n = 1010)
<11 to <22 to 3<11 to <22 to 3<11 to <22 to 3
ACR, American College of Rheumatology; CVD, cardiovascular disease; DAS28, Disease Activity score 28; DMARD, disease-modifying anti-rheumatic drug; HAQ, Health Assessment Questionnaire; IQR, interquartile range; pyr, person-year; RA, rheumatoid arthritis; RF, rheumatoid factor.
HAQ group, n (%)643 (59)328 (30)115 (11)590 (58)312 (31)108 (11)657 (65)254 (25)99 (10)
Female, n (%)388 (60)234 (71)83 (72)361 (61)226 (72)78 (72)404 (61)184 (72)77 (78)
Median (IQR) age at onset (years)51 (39–62)55 (43–69)65 (53–74)52 (39–62)56 (43.5–69)65 (52.5–73)53 (40–63)55 (44–69)66 (51–73)
Median (IQR) swollen and tender joint count1 (0–5)6 (2–11.5)11 (4–19)2 (0-5)6 (2–12)10.5 (4–18.5)0 (0–2)2 (0–7)4 (2–12)
RF titre ⩾1:40 at baseline, n (%)149 (23)78 (24)39 (34)136 (23)77 (25)35 (32)154 (23)61 (24)33 (33)
RF titre ⩾1:80 at baseline, n (%)117 (18)67 (20)33 (29)108 (18)66 (21)30 (28)124 (19)52 (20)28 (28)
Satisfy ACR criteria at baseline, n (%)203 (32)196 (60)92 (80)189 (32)189 (61)86 (80)243 (37)146 (57)75 (76)
Mean (95% CI) DAS28 score3.36 (3.3 to 3.5)4.71 (4.6 to 4.8)5.55 (5.4 to 5.8)3.38 (3.3 to 3.5)4.72 (4.6 to 4.9)5.53 (5.3 to 5.7)3.63 (3.5 to 3.7)4.54 (4.4 to 4.7)5.27 (5.04 to 5.5)
Treated with DMARDs by first year, n (%)208 (32)187 (57)79 (69)201 (34)185 (59)77 (71)254 (39)135 (53)74 (75)
All-cause mortality per 1000 pyr over 10 years12.123.539.711.522.135.811.923.138.9
CVD mortality per 1000 pyr over 10 years712.623.36.711.320.66.413.421.3